Combining chemotherapy and tislelizumab with preoperative split-course hypofraction radiotherapy for locally advanced rectal cancer: study protocol of a prospective, single-arm, phase II trial
Introduction Short-course radiotherapy (SCRT) with systemic therapy has the potential to further improve the long-term efficacy in patients with locally advanced rectal cancer (LARC). To maximise the benefits of neoadjuvant therapy for improved prognosis, it is important to determine the optimal mix...
Main Authors: | Pan Chi, Rong Zheng, Zhihua Li, Benhua Xu, Bi-Si Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-03-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/3/e066976.full |
Similar Items
-
Stereotactic hypofractive radiotherapy in the treatment of patients with lung cancer
by: T. N. Borisova, et al.
Published: (2020-12-01) -
Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
by: Jiale Gao, et al.
Published: (2023-02-01) -
Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer
by: Väliaho Vesa, et al.
Published: (2023-09-01) -
PREOPERATIVE SHORT-COURSE RADIOTHERAPY COMBINED WITH CHEMOTHERAPY, LOCAL HYPERTHERMIA AND DELAYED SURGERY IN TREATMENT OF RECTAL CANCER: PHASE II TRIAL
by: A. O. Rasulov, et al.
Published: (2017-01-01) -
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
by: Anchuan Li, et al.
Published: (2022-07-01)